The price-to-peak earnings multiple has slipped to just 11.9x as of Friday’s close matching the lowest it has been since October of 2009. US equity markets fell for the third straight week and have now dropped in...
Read MoreThis morning Bloomberg reported that Abercrombie & Fitch (ANF) CEO Michael Jefferies—who has led the retailer for nearly two decades—has announced that he intends to sell as much as 1.79 million of his...
Read MoreThe price-to-peak earnings multiple has cooled for the second straight week and now rests at just 12.0x. We are at a juncture in the equity market where we can easily make an effective bullish or bearish case for the near...
Read MoreIntel (INTC) has long been known as a dominate hardware producer, with market share for its processors dwarfing that of the competition. It has become such a behemoth in that industry that some analyst’s have been...
Read MoreWe have received a number of emails and calls wondering why we have not published in thus far in August. We apologize to our readers for the extended downtime, but the research blog and weekly market commentary newsletters...
Read MoreAcme Packet (APKT) was a great example of a company that was Overvalued coming into earnings, so that anything less than absolutely outstanding results will pull the stock lower. Today, the communications equipment maker...
Read MoreThis morning Pasadena, CA based regional bank East West Bancorp (EWBC) reported second quarter earnings that saw the company swing to a profit. Net income was about $36.3 million or 21 cents per share, three cents better...
Read MoreReaders of this research blog know that we were too earlier in our support of Sprint Nextel (S) stock, but after reporting the latest earnings report we are more convinced than ever that the stock has the most upside potential...
Read MoreCephalon (CEPH) is a biopharmaceutical company that we have highlighted in the past, and they reported another outstanding quarter after the close on Tuesday. The company’s most successful drug is Provigil, which is...
Read MoreWe are pleased to announce the Bank of New York’s ConvergEx has selected Ockham Research to receive its Best Bullish Stock Selection Award for the second quarter 2010. BNY’s Jaywalk platform is the best...
Read More
